IRRAS
IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients. IRRAS designs, develops, and commercializes neurocritical care products that transform patient outcomes and decrease the overall cost of care by addressing complications associated with current treatment methodologies. IRRAS markets and sells its comprehensive, innovative IRRAflow and Hummingbird ICP Monitoring product lines to hospitals worldwide through its direct sales organization in the United States and select European countries as well as an international network of distribution partners. IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in Munich, Germany, and San Diego, California, USA.
About IRRAS
Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$21MCategory
Sector
Pharmaceutical PreparationsIndustry Group
DrugsIndustry
Medical DevicesLocation
City
StockholmState
StockholmCountry
SwedenIRRAS
Find your buyer within IRRAS